News for 'Drug Administration'

AstraZeneca sues Ranbaxy over Nexium

AstraZeneca sues Ranbaxy over Nexium

Rediff.com23 Nov 2005

AstraZeneca files suit against Ranbaxy

AstraZeneca files suit against Ranbaxy

Rediff.com22 Nov 2005

Global pharma firm AstraZeneca on Tuesday said it had filed a lawsuit in the United States District Court of New Jersey

Cipla gets nod to import Moderna vaccine for emergency use in India

Cipla gets nod to import Moderna vaccine for emergency use in India

Rediff.com29 Jun 2021

India's drug regulator Drugs Controller General of India has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, official sources said on Tuesday.

FDA asks stent makers to get DGCI approval

FDA asks stent makers to get DGCI approval

Rediff.com13 Jun 2005

Acting swiftly on the controversy regarding illegal drug-coated stents, the Maharashtra Food and Drug Administration has asked all stent manufacturers and importers to get valid licenses within the next two months from the Drugs Controller General of

Former Ranbaxy promoters fined Rs 2,600 crore

Former Ranbaxy promoters fined Rs 2,600 crore

Rediff.com5 May 2016

The US arm of Ranbaxy pleaded guilty to seven felonies relating to the manufacture and distribution of certain adulterated drugs

Govt in talks with Pfizer, J&J for supply of vaccines to India

Govt in talks with Pfizer, J&J for supply of vaccines to India

Rediff.com2 Jun 2021

The central government is importing COVID-19 vaccines and is in talks with COVID-19 vaccine manufacturers Pfizer and Johnson & Johnson, Union Minister of State for Home Affairs G Kishan Reddy said.

Ranbaxy gets USFDA nod for generic Serzone

Ranbaxy gets USFDA nod for generic Serzone

Rediff.com28 Apr 2003

The United States Food and Drugs Administration has granted Ranbaxy Laboratories a tentative approval to market a generic form of Bristol-Myers' anti-depressant Serzone, US FDA's web site said.

Why Ranbaxy's big setback is not yet over

Why Ranbaxy's big setback is not yet over

Rediff.com18 Sep 2013

US drug regulator's fiat on Mohali factory, after strictures on the two other major Indian units, has numerous negative implications.

Pfizer, BioNTech claim their Covid vaccine over 90% effective

Pfizer, BioNTech claim their Covid vaccine over 90% effective

Rediff.com10 Nov 2020

After discussion with the Food and Drug Administration (FDA), the companies recently elected to drop the 32-case interim analysis and conduct the first interim analysis at a minimum of 62 cases, the statement said.

Raja Krishnamoorthi on why so many Indian Americans are running for office

Raja Krishnamoorthi on why so many Indian Americans are running for office

Rediff.com5 Nov 2020

With an increasing number of people from the Indian-American community playing a significant role in US elections, Congressman Raja Krishnamoorthi said there is a realisation among them that "if you don't have a seat at the table, you're on the menu -- that is why they are voting and running for office in large numbers".

Sun Pharma gets USFDA nod for anti-cancer injection

Sun Pharma gets USFDA nod for anti-cancer injection

Rediff.com5 Feb 2013

This generic Doxorubicin HCl Liposome injection USP, 2 mg/ml is therapeutically equivalent to Doxil Liposome Injection, 2 mg/ml of Janssen Research and Development, LLC.

1 dead in Aurangabad violence, 7 held for attack on police station

1 dead in Aurangabad violence, 7 held for attack on police station

Rediff.com31 Mar 2023

Normalcy returned to the city, recently renamed as 'Chhatrapati Sambhajinagar', even as the government deployed five companies of the State Reserve Police Force as a precaution.

Why Daiichi is taking Malvinder Singh to court

Why Daiichi is taking Malvinder Singh to court

Rediff.com27 Nov 2013

The Japanese company alleges the earlier Ranbaxy promoters withheld crucial information when they sold the company in 2008.

Cadila gets tentative FDA nod

Cadila gets tentative FDA nod

Rediff.com15 Jun 2006

Cadila Healthcare Ltd has received tentative approval from the USFDA to market Pravastatin Sodium Tablets in the US market.

Why Wockhardt's Waluj facility is under lens

Why Wockhardt's Waluj facility is under lens

Rediff.com18 Nov 2013

After recovering from issues such as defaults on foreign currency convertible bonds and piling debts, pharmaceutical major Wockhardt has been on the slow lane through the last six months, following warnings from global regulators such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare Products Regulatory Agency.

Cloud over US FDA inspection

Cloud over US FDA inspection

Rediff.com19 Jul 2008

Two US Congress members have expressed doubts over the quality of inspections conducted by the US Food and Drugs Administration (FDA) on Indian drug manufacturing facilities.

Meet India's 10 new dollar billionaires

Meet India's 10 new dollar billionaires

Rediff.com22 Jul 2014

The number of dollar billionaires in India has risen to 55 this year from 46 last year.

Taro faces ban on products in US market

Taro faces ban on products in US market

Rediff.com11 Feb 2009

If Taro fails to address the issues raised by the US Food and Drug Administration, it may face ban on many of its products in the US market, made from the facility at Ontorio, Canada. If Taro fails to address the issues raised by the US Food and Drug Administration, it may face ban on many of its products in the US market, made from the facility at Ontorio, Canada. If Taro fails to address the issues raised by the US FDA, it may face ban on many of its products.

Lupin pills hit legal wall in United States

Lupin pills hit legal wall in United States

Rediff.com12 Oct 2009

Teva Women's Health filed a suit this week in the US District Court for New Jersey, claiming that Lupin had filed an abbreviated new drug application with the US Food and Drug Administration, which infringes the patents of Seasonale, its oral contraceptive that limits the number of menstrual periods women have in a year.

Ranbaxy gets USFDA approval for carvedilol tablets

Ranbaxy gets USFDA approval for carvedilol tablets

Rediff.com25 Oct 2004

Pharmaceutical giant Ranbaxy on Monday said that it has received tentative approval from the US Food and Drug Administration to manufacture and market carvedilol tablets for treatment of cardiac disorders including hypertension.\n\n\n\n

JB Chem files 1st ANDA, US FDA

JB Chem files 1st ANDA, US FDA

Rediff.com16 Jan 2003

JB Chemicals & Pharmaceuticals Ltd on Thursday announced the filing of its first Abbreviated New Drug Application with the United States Food and Drug Administration.

Now, easy to buy Viagra in China

Now, easy to buy Viagra in China

Rediff.com30 Sep 2004

The popular anti-impotence drug will be available in about 2,000 drugstores in major cities.

Breast milk compound could fight cancer

Breast milk compound could fight cancer

Rediff.com26 Feb 2008

A slight variation of lactoferrin, known as talactoferrin alfa, helps fight lung cancer, according to research by Dr Atul Varadhachary, president and chief operating officer of the Houston-based Agennix.

US President Biden gets COVID-19 vaccine booster shot

US President Biden gets COVID-19 vaccine booster shot

Rediff.com28 Sep 2021

Biden got a third Pfizer dose after booster doses were approved by federal health officials.

USFDA to set up office in India

USFDA to set up office in India

Rediff.com18 Nov 2008

The US Department of Health and Human Services has decided to employ 10 full-time officials in Delhi -- a country director, four drug inspectors, two senior technical experts in medicines, two technical experts in medical devices and one from the food sector. 'The purpose of the appointment is to help develop food and medical product regulations and agencies improve product safety and conduct inspections in a more timely manner,' said Christopher Kelly, press officer, USFDA.

DGCA to make drug test a must for pilots, crew members

DGCA to make drug test a must for pilots, crew members

Rediff.com26 Aug 2021

The Directorate General of Civil Aviation (DGCA) has released a draft procedure that calls for testing pilots, other aviation personnel and crew members for psychoactive substances before they take to the skies. The Indian civil aviation regulator has sought comments from stakeholders over the next 30 days before issuing a regulation to this effect. Asking airlines and airports to do random checks on crew and air traffic controllers, DGCA proposed that violators be suspended for a minimum of three years or their licence be permanently cancelled as maximum punishment.

Dr Reddy's files for generic Allegra in US

Dr Reddy's files for generic Allegra in US

Rediff.com26 Mar 2003

Indian drugmaker Dr Reddy's Laboratories Ltd said on Wednesday it has filed with the US Food and Drug Administration to market a generic version of Aventis Pharmaceuticals' anti-allergy drug Allegra.

Ranbaxy gets USFDA nod for Atenolol tabs

Ranbaxy gets USFDA nod for Atenolol tabs

Rediff.com2 Jan 2007

Ranbaxy Pharmaceuticals Inc said on Tuesday it has received US Food and Drug Administration's approval for manufacturing and marketing cardiovascular drug -- Atenolol tablets in the US.

Zika virus detected in K'taka dist, govt urges people not to panic

Zika virus detected in K'taka dist, govt urges people not to panic

Rediff.com2 Nov 2023

The virus was detected in Aedes aegypti mosquitoes after samples from six water bodies in Chikkaballapura were collected and sent for examination.

Wockhardt hit by FDA alert on another plant

Wockhardt hit by FDA alert on another plant

Rediff.com27 Nov 2013

Its factory in Chikalthana in western India was last month hit by the British drug regulator's curb on imports from the plant over manufacturing deficiencies.

Hotelier Vikram Chatwal held in US with drugs, released

Hotelier Vikram Chatwal held in US with drugs, released

Rediff.com5 Apr 2013

According to the TMZ website, the multi-millionaire hotel owner was arrested on April 2 at the Fort Lauderdale/Hollywood International Airport after Transportation Security Administration (TSA) officials found an "arsenal of drugs", including cocaine, weed, heroin and various prescription pills hidden on his person and in his bag.

It's a tough road ahead for pharma companies

It's a tough road ahead for pharma companies

Rediff.com29 May 2013

Post Ranbaxy episode, domestic pharma companies may face frequent inspections and deeper scrutiny.

Wockhardt staring at a crisis?

Wockhardt staring at a crisis?

Rediff.com25 May 2013

Wockhardt might be headed for another crisis, as it has come under the scanner of US health regulator.

'We are looking at flying an Indian into space'

'We are looking at flying an Indian into space'

Rediff.com8 Dec 2023

'It's vital that over the next 10 years, that India, the US and the Artemis Accords family of nations come together to ensure that we not only return humanity to the moon, but that we build the technology that will allow us stay there permanently.' 'And then go on to Mars.'

20-30% new products may be open to USFDA inspection

20-30% new products may be open to USFDA inspection

Rediff.com23 May 2022

With all major US export-oriented drug manufacturing plants in the country up for inspection in 2022, some estimates peg that at least 20-30 per cent of the new product launches lined up for the US will be subject to on-site inspection by the US Food and Drug Administration (USFDA). The last two years saw limited physical inspections due to travel restrictions during the pandemic. "Pre-Covid, the frequency and number of inspections of manufacturing plants in India by USFDA had increased significantly," analysts from ICICI Securities Research noted. "With growing ANDA filings, especially for complex products. "We expect this trend to return with the environment normalising," analysts from ICICI Securities Research noted.

Where to buy medicines during Mumbai's chemists strike

Where to buy medicines during Mumbai's chemists strike

Rediff.com14 Oct 2012

The Maharashtra State Chemists and Druggists Association has called for a three-day token strike from October 16-18, to protest alleged harassment by the Food and Drugs Administration officials.

Ranbaxy gets USFDA nod for Dispermox

Ranbaxy gets USFDA nod for Dispermox

Rediff.com14 Aug 2003

Ranbaxy Laboratories, in a release issued to the BSE on Thursday, said the US Food and Drug Administration has granted the company permission to market DisperMox (amoxicillin tablets for oral suspension - 200mg and 400mg).\n\n